
Triple-receptor metabolic mastery.
Retatrutide-class triple agonist for next-generation fat loss.
Triple GLP is a next-generation GLP-1 / GIP / Glucagon triple agonist designed for advanced metabolic recomposition.
Triple receptor activation amplifies satiety, insulin sensitivity, and basal energy expenditure for compounded metabolic effect.
2 mg weekly to start, titrated upward. 16-week minimum cycle.
Weekly subcutaneous injection. Rotate between abdomen, thigh, and upper arm.
Refrigerate at 2–8 °C. Protect from light.
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.
MetabolicSLU-PP-332 AMPK activator that mimics the metabolic signature of endurance training.
MetabolicRetatrutide 50mg/3mL — triple agonist of GLP-1, GIP, and Glucagon receptors.
MetabolicTirzepatide 60mg/3mL — GLP-1 / GIP dual agonist for advanced fat loss.
MetabolicPre-filled 60mg/3ml MOTS-c pen — mitochondrially encoded peptide that boosts metabolic flexibility.